Home Newsfeeds Savara Q2 EPS $(0.06) Up From $(0.07) YoY

Savara Q2 EPS $(0.06) Up From $(0.07) YoY

Savara (NASDAQ:SVRA) reported quarterly losses of $(0.06) per share. This is a 14.29 percent increase over losses of $(0.07) per share from the same period last year.

byBenzinga Newsdesk

August 11, 2022

1 minute read

Savara (NASDAQ:SVRA) reported quarterly losses of $(0.06) per share. This is a 14.29 percent increase over losses of $(0.07) per share from the same period last year.

Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June 7): Are These In Your Portfolio?

By Lekha Gupta

June 9, 2:29 PM

Mid-cap stocks saw significant gains last week, with top performers like AGIO, VRNT, and NVAX, causing analysts to raise their forecasts.

ACLS

A Milestone Phase I Randomized, Double-Blind Clinical Trial Demonstrates High-Dose Niagen, Patented Nicotinamide Riboside, Supplementation Induces A Potent NAD+ Response And Is Associated With Mild Improvement In Parkinson’s Disease

By Benzinga Newsdesk

November 30, 9:36 AM

Building on a growing body of research showcasing NR as a potential therapeutic strategy for PD, this is the first clinical study to showcase the safety, tolerability, and beneficial metabolic effects of high-dose NR at

CDXC

Equinix Forms Its Second Joint Venture With PGIM Real Estate – What’s On The Cards?

By Shivani Kumaresan

April 15, 11:35 AM

Discover the latest collaboration between Equinix and PGIM Real Estate, forming a $600 million joint venture to develop the first xScale data center in the U.S.

EQIX